Overview

Etanercept and Vascular Function in Psoriasis

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The investigators plan to measure the health of the vascular system of subjects taking Etanercept for the treatment of plaque psoriasis.
Phase:
Phase 2
Details
Lead Sponsor:
Emory University
Collaborator:
Amgen
Treatments:
Etanercept